je.st
news
Why Genzyme isn't worried about a threat by Amicus to its next Fabry drug
2015-07-20 20:46:31| Biotech - Topix.net
It's been less than a year since Genzyme started offering the first-ever pill to treat the very rare disease known as Gaucher. Now it's one of two big drug companies in the world aiming to do the same thing with a related rare disease, called Fabry.
Tags: its
next
drug
threat
Category:Biotechnology and Pharmaceuticals